We are live on
!
Find out more
Wasatch Advisors Portfolio holdings
AUM
$13.5B
Turnover
19.35%
1-Year Est. Return
16.58%
This Fund
S&P 500
This Quarter
Est. Return
+9.24%
1 Year Est. Return
+16.58%
3 Year Est. Return
+83.9%
5 Year Est. Return
+72.34%
10 Year Est. Return
+761.06%
AUM
$22.3B
AUM Growth
+$1.95B
(+9.6%)
Cap. Flow
+$816M
Cap. Flow
% of AUM
3.66%
Top 10 Holdings %
Top 10 Hldgs %
19.29%
Holding
287
New
35
Increased
136
Reduced
90
Closed
21
Avg Time Held
2.6
years
Top 10 Avg Time Held
0.6
years
Top 20 Avg Time Held
1.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Grand Canyon Education
LOPE
|
+$99.5M |
| 2 |
StepStone Group
STEP
|
+$99M |
| 3 |
Open Lending Corp
LPRO
|
+$75.7M |
| 4 |
JIH
Juniper Industrial Holdings, Inc.
JIH
|
+$68.3M |
| 5 |
Neogen
NEOG
|
+$65.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$145M |
| 2 |
HubSpot
HUBS
|
+$140M |
| 3 |
Planet Fitness
PLNT
|
+$121M |
| 4 |
Paylocity
PCTY
|
+$117M |
| 5 |
Euronet Worldwide
EEFT
|
+$94.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.92% |
| 2 | Healthcare | 19.85% |
| 3 | Consumer Discretionary | 18.16% |
| 4 | Industrials | 17.53% |
| 5 | Financials | 11.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Tandem Diabetes Care
TNDM
$1.15B
| $32.2M | 0.14% |
364,969
+108,829
| +42% | +$10.1M |
2013 Q4
29 quarters
|
|
127
Nurix Therapeutics
NRIX
$2.73B
| $32.2M | 0.14% |
+1,035,701
| New | +$39.2M |
2021 Q1
0 quarters
|
|
128
iShares MSCI India Small-Cap ETF
SMIN
$719M
| $31.7M | 0.14% |
647,270
+174,622
| +37% | +$8.17M |
2019 Q1
8 quarters
|
|
129
Kulicke & Soffa
KLIC
$4.35B
| $31.7M | 0.14% |
+644,677
| New | +$28M |
2021 Q1
0 quarters
|
|
130
XPEL
XPEL
$1.22B
| $31.3M | 0.14% |
603,601
+115,434
| +24% | +$6.21M |
2020 Q3
2 quarters
|
|
131
AtriCure
ATRC
$2.94B
| $31.2M | 0.14% |
475,652
-65,893
| -12% | -$4.06M |
2013 Q2
31 quarters
|
|
|
TRHC
132
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $30.8M | 0.14% |
668,722
+296,385
| +80% | +$14.1M |
2017 Q3
14 quarters
|
|
133
Inovio Pharmaceuticals
INO
$108M
| $29.6M | 0.13% |
265,973
-62,279
| -19% | -$8.19M |
2014 Q2
27 quarters
|
|
134
Exagen
XGN
$207M
| $29.6M | 0.13% |
1,691,507
+647,104
| +62% | +$11.5M |
2019 Q3
6 quarters
|
|
135
DELISTED
Markforged Holding Corporation
MKFG
| $29.2M | 0.13% |
+252,073
| New | +$29M |
2021 Q1
0 quarters
|
|
136
Atara Biotherapeutics
ATRA
$96.9M
| $29.2M | 0.13% |
81,278
+2,232
| +3% | +$987K |
2018 Q1
12 quarters
|
|
137
Sanmina
SANM
$10.1B
| $28.5M | 0.13% |
688,899
+73,191
| +12% | +$2.66M |
2020 Q2
3 quarters
|
|
138
DELISTED
Cantaloupe
CTLP
| $28.3M | 0.13% |
2,474,671
+760,083
| +44% | +$8.01M |
2020 Q4
1 quarter
|
|
139
LoveSac
LOVE
$213M
| $28.2M | 0.13% |
498,772
-217,990
| -30% | -$12.1M |
2018 Q2
11 quarters
|
|
140
DocuSign
DOCU
$14.5B
| $27.9M | 0.13% |
137,650
+2,540
| +2% | +$589K |
2018 Q2
11 quarters
|
|
141
Tower Semiconductor
TSEM
$23.7B
| $27.8M | 0.12% |
991,908
+287,032
| +41% | +$8.46M |
2015 Q2
23 quarters
|
|
142
MasterCraft Boat Holdings
MCFT
$485M
| $27.6M | 0.12% |
1,038,799
+121,278
| +13% | +$3.36M |
2019 Q1
8 quarters
|
|
143
Commercial Metals
CMC
$7.23B
| $27.4M | 0.12% |
+888,676
| New | +$22M |
2021 Q1
0 quarters
|
|
144
Denali Therapeutics
DNLI
$2.93B
| $27.3M | 0.12% |
478,442
-2,842
| -0.6% | -$190K |
2017 Q4
13 quarters
|
|
145
Korro Bio
KRRO
$137M
| $27M | 0.12% |
56,924
-12,731
| -18% | -$24.7M |
2019 Q4
5 quarters
|
|
146
US Physical Therapy
USPH
$1.28B
| $26.9M | 0.12% |
258,037
+87,462
| +51% | +$10.9M |
2020 Q1
4 quarters
|
|
|
EBIX
147
DELISTED
Ebix Inc
EBIX
| $26.9M | 0.12% |
838,366
+154,620
| +23% | +$5.96M |
2013 Q2
31 quarters
|
|
148
Minerals Technologies
MTX
$1.98B
| $26.8M | 0.12% |
355,867
+22,904
| +7% | +$1.62M |
2019 Q4
5 quarters
|
|
149
National CineMedia
NCMI
$212M
| $26.7M | 0.12% |
578,704
+90,203
| +18% | +$3.98M |
2019 Q3
6 quarters
|
|
150
Patrick Industries
PATK
$2.19B
| $26.3M | 0.12% |
464,652
-11,769
| -2% | -$616K |
2014 Q4
25 quarters
|
|
Similar funds
Wasatch Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, Wasatch Advisors held 287 positions worth $22.3B, up 9.6% from $20.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Wasatch Advisors deployed $816M of net new capital in Q1 2021, opening 35 new positions and adding to 136 existing holdings. Its largest new stake was Grand Canyon Education: 1,001,405 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Ligand Pharmaceuticals, an estimated $145M trimmed.
- Wasatch Advisors's largest Q1 2021 buy was Grand Canyon Education: 1,001,405 shares worth $107M.
- Wasatch Advisors added most to StepStone Group in Q1 2021, an estimated $99M increase.
- Wasatch Advisors's biggest Q1 2021 reduction was Ligand Pharmaceuticals, cutting an estimated $145M.
- Wasatch Advisors fully exited Planet Fitness in Q1 2021, selling an estimated $121M.
- Wasatch Advisors's ten largest holdings make up 19% of its $22.3B portfolio in Q1 2021.
- Wasatch Advisors opened 35 new positions and closed 21 in Q1 2021.
- Wasatch Advisors's portfolio value rose 9.6% quarter-over-quarter to $22.3B.
Based on Wasatch Advisors's 13F filing for Q1 2021, filed 10 May 2021.